5 completed, 1 unknown. 6 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 6 | Completed 5, Unknown 1 |
Follow Insulin Sensitivity: new trials by email Literature Review of Insulin Sensitivity trials Research Report on Insulin Sensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM REMD-477, Placebo Subcutaneous injection - Type 2 Diabetes, Glucose Tolerance Impaired | Early Phase 1 | Completed | The University of Texas Health Science Center at San Antonio | 4 | 2021-11-10 | 2024-08-09 |
| Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes Empagliflozin 25 MG - Type2 Diabetes, Insulin Sensitivity | Early Phase 1 | Unknown | University of Virginia | 50 | 2020-02-01 | 2022-02-10 |
| Low Dose Fat-Induced Insulin Resistance Intralipid, 20% Intravenous Emulsion - Diabetes Mellitus, Type 2, Insulin Resistance | Early Phase 1 | Completed | University of Pennsylvania | 9 | 2020-01-01 | 2026-04-15 |
| Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults Octreotide, Insulin, Dextrose 20% solution - Vascular Stiffness, Insulin Sensitivity | Early Phase 1 | Completed | University of Virginia | 15 | 2019-02-04 | 2022-05-13 |
| Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism Glucagon Infusion, Saline - Insulin Sensitivity | Early Phase 1 | Completed | The University of Texas Health Science Center at San Antonio | 10 | 2018-02-05 | 2024-10-21 |
| The Effects of Sea Buckthorn and Strawberry on Postprandial Glycaemia, Insulinemia and Appetite Meal sequence 1-2-3, Meal sequence 1-3-2, Meal sequence 2-3-1 - Insulin Sensitivity, Glucose Intolerance | Early Phase 1 | Completed | University of Copenhagen | 18 | 2012-10-01 | 2015-04-09 |
Insulin Resistance (6) · Diabetes Mellitus, Type 2 (2) · Glucose Intolerance (2)
Glucose Metabolism Disorders (6) · Hyperinsulinism (6) · Metabolic Diseases (6) · Nutritional and Metabolic Diseases (6) · Diabetes Mellitus (2) · Endocrine System Diseases (2) · Hyperglycemia (2)
Glucagon (1) · Glucose (1) · Insulin (1) · Octreotide (1) · Saline Solution (1) · Sodium Chloride (1) · Solutions (1) · empagliflozin (1) · soybean oil, phospholipid emulsion (1) · volagidemab (1)
The University of Texas Health Science Center at San Antonio (2) · University of Virginia (2) · University of Copenhagen (1) · University of Pennsylvania (1)
United States (5) · Denmark (1)
Ralph DeFronzo, MD (2) · Eugene J Barrett, MD PhD (1) · Lars O Dragsted, Ph.D. (1) · Zoltan P Arany, MD, PhD (1)
R01HL142250 (1), T32DK007646 (1)